Avestar Capital’s Zimmer Biomet ZBH Stock Holding History

Avestar Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,412	Closed	-$308K	–	410
2022 Q1	$308K	Buy	2,412 +131	+6%	+$15.8K	0.05%	309
2021 Q4	$281K	Buy	2,281 +445	+24%	+$58.2K	0.03%	356
2021 Q3	$261K	Buy	1,836 +254	+16%	+$37.4K	0.03%	372
2021 Q2	$247K	Buy	+1,582	New	+$256K	0.03%	364
2019 Q3	–	Sell	-11	Closed	-$1K	–	870
2019 Q2	$1K	Hold	11	–	–	﹤0.01%	818
2019 Q1	$1K	Sell	11 -15	-58%	-$1.71K	﹤0.01%	807
2018 Q4	$2K	Sell	26 -2	-7%	-$225	﹤0.01%	662
2018 Q3	$1K	Sell	28 -77	-73%	-$9.15K	﹤0.01%	783
2018 Q2	$8K	Buy	105 +72	+218%	+$7.84K	0.01%	505
2018 Q1	$1K	Buy	33 +14	+74%	+$1.63K	﹤0.01%	793
2017 Q4	$1K	Buy	+19	New	+$2.15K	﹤0.01%	727

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Avestar Capital's ZBH Position: Q2 2022 in Review

Avestar Capital sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 2,412 shares — an estimated $308K sold.

Avestar Capital first reported a position in ZBH in Q4 2017 and held it in 11 quarters. The position peaked at $308K in Q1 2022. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Avestar Capital reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
Avestar Capital sold 2,412 Zimmer Biomet shares in Q2 2022, an estimated $308K.
Avestar Capital first reported a position in Zimmer Biomet in Q4 2017 and held it in 11 quarters.
Avestar Capital's Zimmer Biomet position peaked at $308K in Q1 2022.
956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Avestar Capital's 13F filing for Q2 2022, filed 28 Jul 2022.